DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $766,840 | -7.1% | 3,069 | -7.1% | 0.19% | -11.6% |
| Q1 2024 | $825,100 | +5.0% | 3,304 | -2.7% | 0.22% | +0.5% |
| Q4 2023 | $785,749 | -8.0% | 3,397 | -1.3% | 0.22% | -23.5% |
| Q3 2023 | $853,804 | -73.7% | 3,441 | -73.6% | 0.28% | -73.1% |
| Q2 2023 | $3,247,388 | -1.5% | 13,036 | -0.4% | 1.04% | -0.9% |
| Q1 2023 | $3,297,436 | +72659.0% | 13,083 | -23.4% | 1.05% | -30.4% |
| Q4 2022 | $4,532 | -99.9% | 17,073 | +2.4% | 1.51% | +0.9% |
| Q3 2022 | $4,306,000 | +20.7% | 16,672 | +18.4% | 1.50% | -44.8% |
| Q2 2022 | $3,569,000 | -11.7% | 14,077 | +2.1% | 2.71% | +3.5% |
| Q1 2022 | $4,044,000 | -7.7% | 13,786 | +3.6% | 2.62% | +1.5% |
| Q4 2021 | $4,380,000 | +13.3% | 13,313 | +4.9% | 2.58% | +5.6% |
| Q3 2021 | $3,865,000 | +16.2% | 12,697 | +3.1% | 2.45% | +12.8% |
| Q2 2021 | $3,327,000 | +20.6% | 12,316 | +0.5% | 2.17% | +6.2% |
| Q1 2021 | $2,759,000 | +5.1% | 12,257 | +3.7% | 2.04% | +30.9% |
| Q4 2020 | $2,625,000 | +8.2% | 11,815 | +4.9% | 1.56% | -19.0% |
| Q3 2020 | $2,426,000 | +29.7% | 11,266 | +6.5% | 1.93% | +22.3% |
| Q2 2020 | $1,871,000 | +10.8% | 10,581 | -13.2% | 1.58% | +3.2% |
| Q1 2020 | $1,688,000 | +3.6% | 12,193 | +14.8% | 1.53% | +28.0% |
| Q4 2019 | $1,629,000 | – | 10,617 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |